Angina Pectoris Drugs Market by Type, Drugs, Route of Administration, Distribution Channel, End-Users - Global Forecast 2025-2030- Product Image

Sale

Angina Pectoris Drugs Market by Type, Drugs, Route of Administration, Distribution Channel, End-Users - Global Forecast 2025-2030

Report
187 Pages
October 2024
Region: Global
360iResearch™
ID: 5715602

UP TO €692EUR$697USD£576GBP OFF until Dec 31^st 2024

The Angina Pectoris Drugs Market grew from USD 1.14 billion in 2023 to USD 1.20 billion in 2024. It is expected to continue growing at a CAGR of 5.39%, reaching USD 1.65 billion by 2030.

The angina pectoris drug market encompasses pharmacological treatments meant to alleviate the cardiac chest pain resulting from ischemia, primarily by improving blood flow to the heart muscle or reducing its oxygen demand. This market's necessity arises from the growing prevalence of cardiovascular diseases globally, driven by lifestyle factors such as poor diet, lack of exercise, and increased stress. Application-wise, drugs in this segment include beta-blockers, nitrates, calcium channel blockers, and antiplatelet agents. The end-use scope predominantly involves hospitals, clinics, and outpatient care centers managing chronic and acute angina episodes. Key growth influencers include the increasing incidence of heart diseases, ongoing advancements in drug formulations, and rising awareness of early diagnosis and treatment. An aging global population further contributes, as the risk of angina escalates with age. Emerging opportunities lie in the development of novel therapeutics, personalized medicine approaches, and combination therapies that enhance patient outcomes. Recommendations to seize these opportunities include investment in R&D for innovative drug delivery systems and active collaboration with healthcare providers for clinical trials. However, challenges such as stringent regulatory frameworks, high R&D costs, and potential side effects or interactions of current drugs with other medications impede growth. Additionally, generic drug competition might pressure pricing strategies, affecting profit margins. To overcome these limitations, companies can focus on innovative areas such as precision medicine, exploring genetic targets linked to angina, and leveraging AI-based tools for better patient compliance and monitoring. Insights into the angina pectoris drug market reveal a potential shift towards integrated healthcare models that combine pharmacological advances with lifestyle modifications. By embracing technological innovations and fostering strategic partnerships across industry players, stakeholders can drive significant growth in this evolving healthcare domain.

Understanding Market Dynamics in the Angina Pectoris Drugs Market

The Angina Pectoris Drugs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing burden of lifestyle diseases couple with rise in cases of heart related disorders
- Augmentation of novel drug delivery systems
- Government suppport in strengthening the prevention and control of cardiovascular disease
Market Restraints
- Concerns regarding side effects associated with certain drug classes
Market Opportunities
- Technological advancements towards personalized cardiovascular medicine
- Proliferation in the number of drug approvals and clinical research
Market Challenges
- Dearth of skilled and experienced professionals

Exploring Porter’s Five Forces for the Angina Pectoris Drugs Market

Porter’s Five Forces framework further strengthens the insights of the Angina Pectoris Drugs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Angina Pectoris Drugs Market

External macro-environmental factors deeply influence the performance of the Angina Pectoris Drugs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Angina Pectoris Drugs Market

The Angina Pectoris Drugs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Angina Pectoris Drugs Market

The Angina Pectoris Drugs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Angina Pectoris Drugs Market

The Angina Pectoris Drugs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Angina Pectoris Drugs Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Limited, Alkem Laboratories Ltd., Astellas Pharma Inc., AstraZeneca PLC, Bausch Health Companies Inc., Bayer AG, Centurion Remedies Private Limited, Dr. Reddy's Laboratories, Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline PLC, Intas Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Ltd., Macleods Pharmaceuticals Pvt Ltd., Mankind Pharma, Merck & Co. Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Sanofi-Aventis Groupe S.A., Sumitomo Corporation, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Torrent Pharmaceuticals Ltd..

Market Segmentation & Coverage

This research report categorizes the Angina Pectoris Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Prinzmetal Angina
- Stable Angina
- Unstable Angina
Drugs
- Anti-Ischemic Agents
- Antihypertensive Agents
- Antiplatelet Agents
- Beta-Adrenergic Blocking Agents
- Calcium Channel Blockers
- Nitrates
- Statins
Route of Administration
- Oral
- Parenteral
- Transdermal
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
End-Users
- Homecare
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing burden of lifestyle diseases couple with rise in cases of heart related disorders
5.1.1.2. Augmentation of novel drug delivery systems
5.1.1.3. Government suppport in strengthening the prevention and control of cardiovascular disease
5.1.2. Restraints
5.1.2.1. Concerns regarding side effects associated with certain drug classes
5.1.3. Opportunities
5.1.3.1. Technological advancements towards personalized cardiovascular medicine
5.1.3.2. Proliferation in the number of drug approvals and clinical research
5.1.4. Challenges
5.1.4.1. Dearth of skilled and experienced professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Angina Pectoris Drugs Market, by Type

6.1. Introduction
6.2. Prinzmetal Angina
6.3. Stable Angina
6.4. Unstable Angina

7. Angina Pectoris Drugs Market, by Drugs

7.1. Introduction
7.2. Anti-Ischemic Agents
7.3. Antihypertensive Agents
7.4. Antiplatelet Agents
7.5. Beta-Adrenergic Blocking Agents
7.6. Calcium Channel Blockers
7.7. Nitrates
7.8. Statins

8. Angina Pectoris Drugs Market, by Route of Administration

8.1. Introduction
8.2. Oral
8.3. Parenteral
8.4. Transdermal

9. Angina Pectoris Drugs Market, by Distribution Channel

9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy

10. Angina Pectoris Drugs Market, by End-Users

10.1. Introduction
10.2. Homecare
10.3. Hospitals
10.4. Specialty Clinics

11. Americas Angina Pectoris Drugs Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Angina Pectoris Drugs Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Angina Pectoris Drugs Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. ANGINA PECTORIS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ANGINA PECTORIS DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ANGINA PECTORIS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. ANGINA PECTORIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. ANGINA PECTORIS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ANGINA PECTORIS DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PRINZMETAL ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTI-ISCHEMIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIHYPERTENSIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ANTIPLATELET AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY BETA-ADRENERGIC BLOCKING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY NITRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY STATINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANGINA PECTORIS DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 47. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 49. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. CANADA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ANGINA PECTORIS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 74. CHINA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. CHINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 76. CHINA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. CHINA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. CHINA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. INDIA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 81. INDIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. INDIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. INDIA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 89. JAPAN ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. JAPAN ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 91. JAPAN ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. JAPAN ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. JAPAN ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 119. THAILAND ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. THAILAND ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 121. THAILAND ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. THAILAND ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. THAILAND ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. DENMARK ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. DENMARK ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 137. DENMARK ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. DENMARK ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. DENMARK ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 140. EGYPT ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 142. EGYPT ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. EGYPT ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. EGYPT ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 145. FINLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. FINLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. FINLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. FRANCE ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 155. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 157. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. GERMANY ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 165. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 167. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. ITALY ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 180. NORWAY ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 182. NORWAY ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 183. NORWAY ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. NORWAY ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 185. POLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. POLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 187. POLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. POLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 190. QATAR ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. QATAR ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 192. QATAR ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. QATAR ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 210. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 212. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. SPAIN ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 225. TURKEY ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. TURKEY ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. TURKEY ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ANGINA PECTORIS DRUGS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 240. ANGINA PECTORIS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 241. ANGINA PECTORIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Angina Pectoris Drugs Market, which are profiled in this report, include:

Alembic Pharmaceuticals Limited
Alkem Laboratories Ltd.
Astellas Pharma Inc.
AstraZeneca PLC
Bausch Health Companies Inc.
Bayer AG
Centurion Remedies Private Limited
Dr. Reddy's Laboratories
Eli Lilly and Company
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Intas Pharmaceuticals Ltd.
Ipca Laboratories Ltd.
Lupin Ltd.
Macleods Pharmaceuticals Pvt Ltd.
Mankind Pharma
Merck & Co. Inc.
Novartis AG
Otsuka Pharmaceutical Co., Ltd.
Pfizer Inc.
Sanofi-Aventis Groupe S.A.
Sumitomo Corporation
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	187
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.2 Billion
Forecasted Market Value ( USD ) by 2030	$ 1.65 Billion
Compound Annual Growth Rate	5.3%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3522EUR$3,545USD£2,928GBP €3913EUR$3,939USD£3,254GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6231EUR$6,272USD£5,181GBP €6923EUR$6,969USD£5,756GBP

Understanding Market Dynamics in the Angina Pectoris Drugs Market

Exploring Porter’s Five Forces for the Angina Pectoris Drugs Market

Applying PESTLE Analysis to the Angina Pectoris Drugs Market

Analyzing Market Share in the Angina Pectoris Drugs Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Angina Pectoris Drugs Market

Strategic Recommendations for Success in the Angina Pectoris Drugs Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Angina Pectoris Drugs Market Size, Share & Trends Analysis Report By Type (Stable Angina, Unstable Angina), By Drug Class (Beta Blockers, Anticoagulants), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Angina Pectoris Drugs Global Market Report 2024

Angina Pectoris Drugs Market by Type, by Drugs, by Route of Administration, by End-Users, and By Region

Angina Pectoris Drugs - Global Strategic Business Report

Angina (Angina Pectoris) - Market Insight, Epidemiology and Market Forecast - 2034

About the Angina Pectoris Treatment Market